BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32613461)

  • 1. Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study.
    Sharma A; Bandello F; Loewenstein A; Kuppermann BD; Lanzetta P; Zur D; Hilely A; Iglicki M; Veritti D; Wang A; Miassi F; Bellocq D; Zacharias LC; Makam D; Kumar N; Parachuri N; Barriera AK; Sharma R; Faridi H; Mathis T; Kodjikian L
    Int Ophthalmol; 2020 Nov; 40(11):3067-3075. PubMed ID: 32613461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of best corrected visual acuity and central macular thickness after intravitreal dexamethasone implant injections in patients with Irvine-Gass syndrome: A retrospective study of six cases.
    Keilani C; Halalchi A; Wakpi Djeugue D; Regis A; Abada S
    Therapie; 2016 Oct; 71(5):457-465. PubMed ID: 27203164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
    Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
    Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of postoperative cystoid macular edema (Irvine-Gass syndrome) with dexamethasone 0.7 mg intravitreal implant].
    Landré C; Zourdani A; Gastaud P; Baillif S
    J Fr Ophtalmol; 2016 Jan; 39(1):5-11. PubMed ID: 26520410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
    Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
    Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications of intravitreal injections--own experience].
    Jamrozy-Witkowska A; Kowalska K; Jankowska-Lech I; Terelak-Borys B; Nowosielska A; Grabska-Liberek I
    Klin Oczna; 2011; 113(4-6):127-31. PubMed ID: 21913440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflibercept for Diabetic Macular Edema in Eyes Previously Treated With Ranibizumab and/or Bevacizumab May Further Improve Macular Thickness.
    Shah CP; Heier JS
    Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):836-9. PubMed ID: 27631479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal injection of dexamethasone implant and ranibizumab in cystoid macular edema in the course of irvine-gass syndrome.
    Fenicia V; Balestrieri M; Perdicchi A; MauriziEnrici M; DelleFave M; Recupero SM
    Case Rep Ophthalmol; 2014 May; 5(2):243-8. PubMed ID: 25232337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of intravitreal dexamethasone implants in macular edema excluding venous occlusions: results for a cohort of 80 patients].
    Degoumois A; Akesbi J; Laurens C; Rodallec FT; Adam R; Blumen-Ohana E; Laplace O; Virevialle C; Le Dû B; Guyader V; Nordmann JP
    J Fr Ophtalmol; 2015 Feb; 38(2):126-33. PubMed ID: 25592383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aflibercept for Previously Treated Macular Edema Associated with Central Retinal Vein Occlusions: 1-Year Results of the NEWTON Study.
    Khurana RN; Chang LK; Bansal AS; Palmer JD; Wu C; Wieland MR
    Ophthalmol Retina; 2018 Feb; 2(2):128-133. PubMed ID: 31047339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of different anti-vascular endothelial growth factor agents, and dexamethasone implant therapy in patients with serous retinal detachment caused by Irvine-Gass syndrome.
    Karasu B; Kesim E; Celebi ARC
    Eur J Ophthalmol; 2024 Mar; 34(2):510-523. PubMed ID: 37408434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone intravitreal implant for treatment of patients with recalcitrant macular edema resulting from Irvine-Gass syndrome.
    Dutra Medeiros M; Navarro R; Garcia-Arumí J; Mateo C; Corcóstegui B
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3320-4. PubMed ID: 23599334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of hard exudates in diabetic macular edema after short-term intravitreal triamcinolone, dexamethasone implant or bevacizumab injections.
    Shin YU; Hong EH; Lim HW; Kang MH; Seong M; Cho H
    BMC Ophthalmol; 2017 Oct; 17(1):182. PubMed ID: 28974211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluocinolone Acetonide 0.19 mg Implant in Patients with Cystoid Macular Edema Due To Irvine-Gass Syndrome.
    Marques JH; Abreu AC; Silva N; Meireles A; Pessoa B; Melo Beirão J
    Int Med Case Rep J; 2021; 14():127-132. PubMed ID: 33664598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.
    Ashraf M; Souka AA; ElKayal H
    Ophthalmic Surg Lasers Imaging Retina; 2017 Mar; 48(3):230-236. PubMed ID: 28297035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes in diabetic macular edema switched directly or after a dexamethasone implant to a fluocinolone acetonide intravitreal implant following anti-VEGF treatment.
    Rehak M; Busch C; Unterlauft JD; Jochmann C; Wiedemann P
    Acta Diabetol; 2020 Apr; 57(4):469-478. PubMed ID: 31749051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.